Sintx Technologies Inc (SINT)

$3.54 -0.10 (-2.75%)
Market Cap 13.41M
Revenue (ttm) 2.89M
Net Income (ttm) -11.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -381.31%
Debt to Equity Ratio 0.01
Volume 12,500
Avg Vol 212,154
Day's Range N/A - N/A
Shares Out 3.68M
Stochastic %K 20%
Beta 0.63
Analysts Sell
Price Target $16.00

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and polyetherketoneketone. The company was formerly known as Am...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 839 3500
Address:
1885 West 2100 South, Salt Lake City, United States
MoneyPrinterz
MoneyPrinterz Dec. 25 at 4:17 PM
$SINT patent news due
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 23 at 12:15 PM
$SINT made a change to u its significant *
0 · Reply
TheWatcher12
TheWatcher12 Dec. 22 at 2:41 PM
$SINT this company is a scam. 300 million in equity investments and nothing to show for it. Their only price targets are from Ascendiant who is getting paid by $SINT for coverage. Maxim group, stopped coverage in June because this company is not going anywhere.
1 · Reply
SnoopyDog
SnoopyDog Dec. 21 at 12:48 PM
$SINT I assume I know something big is coming here!
1 · Reply
Boston7452
Boston7452 Dec. 21 at 3:23 AM
$SINT Wheres masks and PPE?! ”Deck the halls with masks and sanitizer: NYC’s flu outbreak could hamper holiday plans” ”According to data released Friday by the Centers for Disease Control and Prevention, the hospitalization rate nationwide jumped by 14.3%, with over 9,900 people admitted with the flu.”
1 · Reply
SnoopyDog
SnoopyDog Dec. 19 at 9:09 PM
$SINT that close was unexpected
0 · Reply
thetruth149
thetruth149 Dec. 19 at 6:44 PM
$LAZR ...... 600 Million Volume......INSANITY!!!! $SINT $SIDU $CMCSA $RXRX
1 · Reply
whatabigcockyouhave
whatabigcockyouhave Dec. 19 at 4:38 PM
$SINT at these prices i’ll keep buying. bears always throw dilution out there on biotechs like it’s not the most standard shit ever. FDA approval and commercialization agreement in place, what more do you need to see?
1 · Reply
TheWatcher12
TheWatcher12 Dec. 18 at 10:56 PM
$SINT $300M spent and no revenues. Very expensive science project
1 · Reply
Boston7452
Boston7452 Dec. 18 at 6:54 PM
$SINT "Public company management misrepresentation involves intentionally or recklessly providing false information or omitting material facts in financial reports, press releases, or calls, violating SEC Rule 10b-5. This deceptive practice artificially inflates stock prices, triggering investor lawsuits, regulatory penalties, and potential imprisonment for executives"⬇️ https://investors.sintx.com/news-releases/news-release-details/sintx-receives-issuance-us-patent-silicon-nitride-functionalized
1 · Reply
Latest News on SINT
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

Dec 1, 2025, 8:30 AM EST - 24 days ago

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

Nov 3, 2025, 8:00 AM EST - 7 weeks ago

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

Oct 20, 2025, 7:00 AM EDT - 2 months ago

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

Oct 14, 2025, 7:00 AM EDT - 2 months ago

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

Sep 8, 2025, 7:54 AM EDT - 3 months ago

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

Sep 8, 2025, 7:00 AM EDT - 3 months ago

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

Aug 15, 2025, 7:00 AM EDT - 4 months ago

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

Aug 4, 2025, 7:00 AM EDT - 5 months ago

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

Jun 24, 2025, 8:30 AM EDT - 6 months ago

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 22, 2025, 7:00 AM EDT - 7 months ago

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 15, 2025, 7:05 AM EDT - 8 months ago

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 26, 2025, 8:00 AM EST - 10 months ago

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Feb 20, 2025, 6:15 AM EST - 11 months ago

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Feb 19, 2025, 6:00 AM EST - 11 months ago

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Nov 21, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Nov 19, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

SINTX Technologies Announces Stock Repurchase Program

Nov 18, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Announces Stock Repurchase Program

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Nov 14, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Oct 1, 2024, 8:00 AM EDT - 1 year ago

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Sep 9, 2024, 8:00 AM EDT - 1 year ago

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies to Explore Strategic Opportunities

Jun 18, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies to Explore Strategic Opportunities

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

Jun 12, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

Jun 6, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

May 23, 2024, 9:00 AM EDT - 1 year ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

Apr 29, 2024, 9:14 AM EDT - 1 year ago

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

Apr 3, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

SINTX Technologies Announces Proposed Public Offering of Common Stock

Mar 29, 2024, 4:00 PM EDT - 1 year ago

SINTX Technologies Announces Proposed Public Offering of Common Stock

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Mar 25, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)

Feb 23, 2024, 7:50 AM EST - 1 year ago

Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)

GRI

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

Feb 21, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

SINTX Technologies Announces Closing of $4.0 Million Public Offering

Feb 2, 2024, 2:33 PM EST - 2 years ago

SINTX Technologies Announces Closing of $4.0 Million Public Offering

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

Jan 31, 2024, 9:20 AM EST - 2 years ago

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

Jan 30, 2024, 4:01 PM EST - 2 years ago

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

Jan 23, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Jan 4, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Nov 7, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

Nov 3, 2023, 8:28 AM EDT - 2 years ago

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

ARQT HSCS

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

Oct 11, 2023, 9:00 AM EDT - 2 years ago

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

Aug 17, 2023, 9:00 AM EDT - 2 years ago

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

SINTX Technologies Announces Closing of $12.0 Million Public Offering

Feb 10, 2023, 1:52 PM EST - 3 years ago

SINTX Technologies Announces Closing of $12.0 Million Public Offering

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

Feb 7, 2023, 9:05 PM EST - 3 years ago

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

Jan 19, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

Jan 6, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING

Dec 21, 2022, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE DECEMBER 20, 2022

Dec 19, 2022, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE DECEMBER 20, 2022

SINTX TECHNOLOGIES AWARDED MULTI-YEAR DARPA CONTRACT TO DEVELOP CMCs AND HIGH TEMPERATURE COATINGS FOR TURBINE ENGINES

Oct 26, 2022, 9:00 AM EDT - 3 years ago

SINTX TECHNOLOGIES AWARDED MULTI-YEAR DARPA CONTRACT TO DEVELOP CMCs AND HIGH TEMPERATURE COATINGS FOR TURBINE ENGINES

SINTX Technologies, Inc. Announces Subscriptions of Approximately $4.7 Million from its Rights Offering

Oct 13, 2022, 8:30 AM EDT - 3 years ago

SINTX Technologies, Inc. Announces Subscriptions of Approximately $4.7 Million from its Rights Offering

MoneyPrinterz
MoneyPrinterz Dec. 25 at 4:17 PM
$SINT patent news due
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 23 at 12:15 PM
$SINT made a change to u its significant *
0 · Reply
TheWatcher12
TheWatcher12 Dec. 22 at 2:41 PM
$SINT this company is a scam. 300 million in equity investments and nothing to show for it. Their only price targets are from Ascendiant who is getting paid by $SINT for coverage. Maxim group, stopped coverage in June because this company is not going anywhere.
1 · Reply
SnoopyDog
SnoopyDog Dec. 21 at 12:48 PM
$SINT I assume I know something big is coming here!
1 · Reply
Boston7452
Boston7452 Dec. 21 at 3:23 AM
$SINT Wheres masks and PPE?! ”Deck the halls with masks and sanitizer: NYC’s flu outbreak could hamper holiday plans” ”According to data released Friday by the Centers for Disease Control and Prevention, the hospitalization rate nationwide jumped by 14.3%, with over 9,900 people admitted with the flu.”
1 · Reply
SnoopyDog
SnoopyDog Dec. 19 at 9:09 PM
$SINT that close was unexpected
0 · Reply
thetruth149
thetruth149 Dec. 19 at 6:44 PM
$LAZR ...... 600 Million Volume......INSANITY!!!! $SINT $SIDU $CMCSA $RXRX
1 · Reply
whatabigcockyouhave
whatabigcockyouhave Dec. 19 at 4:38 PM
$SINT at these prices i’ll keep buying. bears always throw dilution out there on biotechs like it’s not the most standard shit ever. FDA approval and commercialization agreement in place, what more do you need to see?
1 · Reply
TheWatcher12
TheWatcher12 Dec. 18 at 10:56 PM
$SINT $300M spent and no revenues. Very expensive science project
1 · Reply
Boston7452
Boston7452 Dec. 18 at 6:54 PM
$SINT "Public company management misrepresentation involves intentionally or recklessly providing false information or omitting material facts in financial reports, press releases, or calls, violating SEC Rule 10b-5. This deceptive practice artificially inflates stock prices, triggering investor lawsuits, regulatory penalties, and potential imprisonment for executives"⬇️ https://investors.sintx.com/news-releases/news-release-details/sintx-receives-issuance-us-patent-silicon-nitride-functionalized
1 · Reply
Geneo12345
Geneo12345 Dec. 18 at 5:46 PM
$SINT Where the SINT OGs at?
0 · Reply
Boston7452
Boston7452 Dec. 17 at 11:38 PM
$SINT Dont think so Watcher. Sintx mgmt has about 1m shares -acquired off market and in options that vest by 2027 if the CFOs RSUs apply to the others. Thats about 15-20% or so of potential OS. Before 2025, mgmt held next to nothing.
0 · Reply
TheWatcher12
TheWatcher12 Dec. 17 at 10:49 PM
$SINT this will continue to be an expensive science project for the foreseeable future
0 · Reply
TheWatcher12
TheWatcher12 Dec. 17 at 9:18 PM
$SINT even the evonik supply agreement is almost worthless. Leading surgeons are reluctant to adopt PEEK as it is, adding custom implants on top of this risk will lead to incredibly slow adoption. And what incentive does Evonik have to license with SINT? None. Just less revenue for them
1 · Reply
Boston7452
Boston7452 Dec. 17 at 7:50 PM
$SINT "Arthroplasty – Agreement with global medical device manufacturer to develop orthopedic implant coatings Wound Care – Prototype development ongoing with two global wound care companies" "(Confidential): Antipathogenic face masks and mask filters"
1 · Reply
Brandon6161
Brandon6161 Dec. 17 at 6:24 PM
$SINT I just heard that Partner Cap Securites put out an Institutional Research Report on SINT. Price target $8.5. Does anyone have it?
0 · Reply
TheWatcher12
TheWatcher12 Dec. 17 at 6:02 PM
$SINT “at this time, we have not had any consideration for an exclusive arrangement”. No buyout/exclusive partnership coming any time soon
0 · Reply
Boston7452
Boston7452 Dec. 17 at 2:27 AM
$SINT one day i expect them to announce partnerships with Solv & ZBH. Then eventually one of them will acquire Sint and merge with the other. I could see thet happening with Sint being the man in the middle.
0 · Reply
TheWatcher12
TheWatcher12 Dec. 17 at 12:14 AM
$SINT Less than 2 quarters until they will need another offering. No more grant revenue…
1 · Reply
Boston7452
Boston7452 Dec. 16 at 11:43 PM
$SINT “Flu Cases Skyrocket in New York City, Earlier Than Expected The city and surrounding region have some of the highest levels of flu-like illness in the United States.”
1 · Reply
amda
amda Dec. 16 at 2:44 PM
$SINT odd action so far....
1 · Reply
BillionerOfKing
BillionerOfKing Dec. 16 at 12:28 PM
$SINT Current Stock Price: $3.59
1 · Reply